In addition to immunotherapy and precision medicine, researchers are exploring the potential of CRISPR gene-editing technology. This tool can precisely alter genes within cancer cells, potentially correcting mutations that cause cancer or making the cells more susceptible to existing treatments.
Another promising area is targeted therapy, which involves drugs that specifically target cancer cells while sparing healthy cells. These therapies are designed to interfere with specific molecules involved in cancer growth and progression.
